Shanada Monestime

Shanada is currently the Director of Community Engaged Research at GO2 for Lung Cancer where she collaborates with community and academic partners to develop interventions to increase access to quality care. Her research interests are centered on the effects of race, social class, and access to care in lung cancer early detection and treatment in populations with a smoking history and radon exposure. In her prior roles, she served as an oncology pharmacist, and an Assistant Professor of Pharmacotherapy in Hematology/Oncology, where she secured grant funding as the principal investigator for several research projects and published several publications on patient-reported outcomes, implementing services for underserved patients, and racial disparities in oncology.

GO2 for Lung Cancer is a national nonprofit patient advocacy organization with extensive experience in patient education and outreach. For more than 25 years, GO2 has connected with communities and provided tailored initiatives to address their needs such as education materials, support groups, clinical trial navigation and matching, and patient/caregiver hotlines. GO2’s scientific research portfolio and extensive connections within the lung cancer screening and clinical care community have led to several community-based health education, outreach, and research initiatives. In addition, GO2 runs the global Lung Cancer Registry to collect patient-reported outcomes and has a lung cancer screening “Centers of Excellence” (COEs) hospital network currently consisting of over 850 hospitals in 42 states that provides a framework for peer-to-peer learning to support the delivery of quality care along the lung care spectrum.